PNES may appear from infancy to adulthood, although their incidence is highest between 15 and 35 years of age.
more common in women (70%–80%) and, among associated factors, a history of head injury, generally mild, appears in 20% of cases.
other factors significantly more prevalent in PNES than in epilepsies are personality disorder, perceived childhood neglect, and an excess of adverse life events in the preceding year.
as a general rule, PNES occur in the presence of witnesses and it is not uncommon for the first seizures to take place in the waiting room.
they are usually more prolonged than epileptic seizures, which rarely last more than 2 to 3 minutes excluding the postictal period. When they include convulsive motor activity, this activity may be asymmetric and asynchronous, show a varying course over the episode and can be modified by external distraction. Other typical features of pseudoseizures are keeping the eyes closed during the episode, maintaining consciousness during the convulsive phase, the occurrence of weeping, and the absence of incontinence, self-injury, and postictal amnesia.
VEEG monitoring is a key tool in differential diagnosis of pseudoseizures and has the advantage of allowing careful observation of the semiology of the episodes.
measurement of serum prolactin levels is useful in patients with suspected PNES.
serum prolactin often rises to 5 to 10 times normal after generalized tonic-clonic seizures and to 2 to 3 times normal after complex partial seizures.
peak serum level is obtained from 15 to 20 minutes after the seizure episode and may return to normal after 60 minutes.
the presence of false-positive (eg. syncope, and, patients with persistent high PRL levels) and false-negative results has caused this test to lose prestige, especially when the seizure shows little motor activity as in complex partial / frontal lobe seizures in which the elevation of prolactin is not significant.
early diagnosis of PNES is very important for their prognosis and course, and early diagnosis has been shown to be associated with a better outcome.
treatment is based on providing clear and honest information to the patient and relatives, and support and continuous direct follow-up by the physician treating the patient's epilepsy.